Search Results

ACNS2031: A Phase 3 Study of Sodium Thiosulfate for the Reduction of Cisplatin-Induced Ototoxicity in Children with Average-Risk Medulloblastoma and Reduced Therapy for Children with Medulloblastoma with Low-Risk Features-STUDY00004171

Medulloblastoma is the most common malignant brain tumor in children. Fortunately, children with medulloblastoma and favorable risk factors...

Current Research: Innovation in Child Healthcare Delivery Lab

Current Research: Innovation in Child Healthcare Delivery Lab

ACcomplisH: A Phase 2, multicenter, double-blind, randomized, placebo-controlled, dose escalation trial evaluating safety, efficacy, and pharmacokinetics of subcutaneous doses of TransCon CNP administered once weekly for 12 months in prepube-STUDY00002415

The trial is a multicenter, double-blind, randomized, placebo-controlled, dose escalation trial of weekly TransCon CNP administered subcutaneously...

Sarah Christine Hofman DeYoung, MD

Sarah Christine Hofman DeYoung, MD specializing in Congenital Diaphragmatic Hernia Program, Pulmonary, Airway and Esophageal Center

Seth Adams, MD

Seth Adams, MD specializing in Hospital Medicine, Thyroid Program

Shawn E Kamps, MD

Shawn E Kamps, MD, Associate Professor

Samantha Jean Mussell, ARNP, DNP

Samantha Jean Mussell, ARNP, DNP specializing in Otolaryngology, Airway and Esophageal Center

Sally E Rampersad, MD

Sally E Rampersad, MD, Director of Quality Improvement, Dept of Anesthesiology, Associate Professor

Samuel Rice-Townsend, MD

Samuel Rice-Townsend, MD, Associate Professor

Safia Hope Emesh Cheeney, MD

Safia Hope Emesh Cheeney, MD, Director, Nuclear Medicine